Follow The Filings

NAMSNewamsterdam Pharma Company

Q2 2023 13F holders among managers we track Latest ownership dossier

Ticker
NAMS
Type
Equity
Class
ORDINARY SHARES
Total reported value (long equity)
Manager Report date Value Shares